{
    "Trade/Device Name(s)": [
        "BD ProbeTec\u2122M Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay",
        "BD ProbeTecTM Neisseria gonorrhoeae (GC) Q* Amplified DNA Assay",
        "BD ProbeTec\u2122 Neisseria gonorrhoeae (GC) Q Amplified DNA Assay"
    ],
    "Submitter Information": "BD Diagnostic Systems",
    "510(k) Number": "K090827",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081825",
        "K062440"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL"
    ],
    "Summary Letter Date": "May 27, 2009",
    "Summary Letter Received Date": "March 26, 2009",
    "Submission Date": "March 25, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.3390"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. direct serological test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Neisseria gonorrhoeae DNA"
    ],
    "Specimen Type(s)": [
        "Female endocervical swab",
        "Male urethral swab",
        "Vaginal swab",
        "Male urine",
        "Female urine",
        "Gynecological specimens in PreservCyt Solution"
    ],
    "Specimen Container(s)": [
        "Extraction Tube",
        "PreservCyt Solution container",
        "LBC Specimen Dilution Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper System"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Fluorescent probe detection",
        "Automated DNA extraction"
    ],
    "Methodologies": [
        "Nucleic Acid Amplification Test (NAAT)",
        "SDA-based DNA detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay using SDA technology for direct qualitative detection of N. gonorrhoeae DNA in multiple specimen types with BD Viper System",
    "Indications for Use Summary": "Qualitative detection of Neisseria gonorrhoeae DNA in endocervical, urethral, vaginal swabs, urine, and PreservCyt gynecological specimens to aid in diagnosis of gonococcal urogenital disease in symptomatic and asymptomatic females and symptomatic males",
    "fda_folder": "Microbiology"
}